Assets (2 total) 2 Total Assets
0 Approved
0 Phase 3 / Filed
2 Phase 1–2 / Early
2 Diseases
Disease: All diseases (2) Breast Cancer (1) Non-Small Cell Lung Cancer (1)
Stage: All stages (2) Approved / Phase 4 (0) Phase 3 / Filed (0) Phase 2 Phase 1 / Preclinical
Quick filter: All (2) Breast Cancer (1) Non-Small Cell Lung Cancer (1)
Showing 2 of 2 assets
Asset ↕ Stage ↓ Target & Modality Disease / Indication ↕ Phase 1/2 CDK2/CDK4 Small molecule
Breast Cancer
HR+/HER2- Metastatic Breast Cancer Phase 1/2 KRAS G12D Small molecule
Non-Small Cell Lung Cancer
Upcoming events (2 total) Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link . The calendar updates when a registry date moves.
2028 (1) February 2028 (1) INV-6452 Phase 1/2 Breast Cancer (Locally Advanced or Metastatic), Advanced Solid Cancers, Metastatic (Stage IV) Breast Cancer, Ovarian Cancer … Est. primary completion 2028-02-04 ·
NCT07612891 ·
CT.gov ↗ What to watch
2029 (1) May 2029 (1) INV-8989 Phase 1/2 Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC, Pancreatic Adenocarcinoma Advanced or Metastatic … Est. primary completion 2029-05 ·
NCT07610798 ·
CT.gov ↗ What to watch
See the full readout calendar ↗
Financial reports No financial reports recorded.